These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

394 related items for PubMed ID: 8977187

  • 1. IL-1 beta convertase (ICE) does not play a requisite role in apoptosis induced in T lymphoblasts by Fas-dependent or Fas-independent CTL effector mechanisms.
    Smith DJ, McGuire MJ, Tocci MJ, Thiele DL.
    J Immunol; 1997 Jan 01; 158(1):163-70. PubMed ID: 8977187
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of CPP32-like proteases prevents granzyme B- and Fas-, but not granzyme A-based cytotoxicity exerted by CTL clones.
    Anel A, Gamen S, Alava MA, Schmitt-Verhulst AM, Piñeiro A, Naval J.
    J Immunol; 1997 Mar 01; 158(5):1999-2006. PubMed ID: 9036942
    [Abstract] [Full Text] [Related]

  • 3. Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity.
    Kataoka T, Shinohara N, Takayama H, Takaku K, Kondo S, Yonehara S, Nagai K.
    J Immunol; 1996 May 15; 156(10):3678-86. PubMed ID: 8621902
    [Abstract] [Full Text] [Related]

  • 4. In vivo rejection of tumor cells dependent on CD8 cells that kill independently of perforin and FasL.
    Lee SH, Bar-Haim E, Machlenkin A, Goldberger O, Volovitz I, Vadai E, Tzehoval E, Eisenbach L.
    Cancer Gene Ther; 2004 Mar 15; 11(3):237-48. PubMed ID: 14739939
    [Abstract] [Full Text] [Related]

  • 5. Identification of a population of CD4+ CTL that utilizes a perforin- rather than a Fas ligand-dependent cytotoxic mechanism.
    Williams NS, Engelhard VH.
    J Immunol; 1996 Jan 01; 156(1):153-9. PubMed ID: 8598456
    [Abstract] [Full Text] [Related]

  • 6. Lack of requirement for SHP-1 in both Fas-mediated and perforin-mediated cell death induced by CTL.
    Takayama H, Lee MH, Shirota-Someya Y.
    J Immunol; 1996 Nov 01; 157(9):3943-8. PubMed ID: 8892626
    [Abstract] [Full Text] [Related]

  • 7. Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively.
    Hashimoto W, Osaki T, Okamura H, Robbins PD, Kurimoto M, Nagata S, Lotze MT, Tahara H.
    J Immunol; 1999 Jul 15; 163(2):583-9. PubMed ID: 10395644
    [Abstract] [Full Text] [Related]

  • 8. Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis.
    Enari M, Talanian RV, Wong WW, Nagata S.
    Nature; 1996 Apr 25; 380(6576):723-6. PubMed ID: 8614469
    [Abstract] [Full Text] [Related]

  • 9. MRL/lpr CD4- CD8- and CD8+ T cells, respectively, mediate Fas-dependent and perforin cytotoxic pathways.
    Benihoud K, Bonardelle D, Bobé P, Kiger N.
    Eur J Immunol; 1997 Feb 25; 27(2):415-20. PubMed ID: 9045912
    [Abstract] [Full Text] [Related]

  • 10. Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways.
    Lowin B, Hahne M, Mattmann C, Tschopp J.
    Nature; 1994 Aug 25; 370(6491):650-2. PubMed ID: 7520535
    [Abstract] [Full Text] [Related]

  • 11. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
    Zimmerman Z, Shatry A, Deyev V, Podack E, Mammolenti M, Blazar BR, Yagita H, Levy RB.
    Biol Blood Marrow Transplant; 2005 Aug 25; 11(8):576-86. PubMed ID: 16041307
    [Abstract] [Full Text] [Related]

  • 12. Tumor regression after adoptive transfer of effector T cells is independent of perforin or Fas ligand (APO-1L/CD95L).
    Winter H, Hu HM, Urba WJ, Fox BA.
    J Immunol; 1999 Oct 15; 163(8):4462-72. PubMed ID: 10510388
    [Abstract] [Full Text] [Related]

  • 13. Regulation of Fas(Apo-1/CD95)- and perforin-mediated lytic pathways of primary cytotoxic T lymphocytes by the protooncogene bcl-2.
    Schröter M, Lowin B, Borner C, Tschopp J.
    Eur J Immunol; 1995 Dec 15; 25(12):3509-13. PubMed ID: 8566045
    [Abstract] [Full Text] [Related]

  • 14. Independent roles of perforin, granzymes, and Fas in the control of Friend retrovirus infection.
    Zelinskyy G, Balkow S, Schimmer S, Schepers K, Simon MM, Dittmer U.
    Virology; 2004 Dec 20; 330(2):365-74. PubMed ID: 15567431
    [Abstract] [Full Text] [Related]

  • 15. Differential involvement of a Fas-CPP32-like protease pathway in apoptosis of TCR/CD9-costimulated, naive T cells and TCR-restimulated, activated T cells.
    Park CS, Yashiro Y, Tai XG, Toyo-oka K, Hamaoka T, Yagita H, Okumura K, Neben S, Fujiwara H.
    J Immunol; 1998 Jun 15; 160(12):5790-6. PubMed ID: 9637489
    [Abstract] [Full Text] [Related]

  • 16. p53-dependent DNA damage-induced apoptosis requires Fas/APO-1-independent activation of CPP32beta.
    Fuchs EJ, McKenna KA, Bedi A.
    Cancer Res; 1997 Jul 01; 57(13):2550-4. PubMed ID: 9205051
    [Abstract] [Full Text] [Related]

  • 17. Apoptosis signaling pathways in normal T cells: differential activity of Bcl-2 and IL-1beta-converting enzyme family protease inhibitors on glucocorticoid- and Fas-mediated cytotoxicity.
    Moreno MB, Memon SA, Zacharchuk CM.
    J Immunol; 1996 Nov 01; 157(9):3845-9. PubMed ID: 8892614
    [Abstract] [Full Text] [Related]

  • 18. Caspase dependence of target cell damage induced by cytotoxic lymphocytes.
    Sarin A, Haddad EK, Henkart PA.
    J Immunol; 1998 Sep 15; 161(6):2810-6. PubMed ID: 9743340
    [Abstract] [Full Text] [Related]

  • 19. Dimethyl 2,2-dichlorovinyl phosphate (DDVP) markedly inhibits activities of natural killer cells, cytotoxic T lymphocytes and lymphokine-activated killer cells via the Fas-ligand/Fas pathway in perforin-knockout (PKO) mice.
    Li Q, Nakadai A, Takeda K, Kawada T.
    Toxicology; 2004 Nov 01; 204(1):41-50. PubMed ID: 15369847
    [Abstract] [Full Text] [Related]

  • 20. Two types of anti-TL (thymus leukemia) CTL clones with distinct target specificities: differences in cytotoxic mechanisms and accessory molecule requirements.
    Tsujimura K, Takahashi T, Iwase S, Matsudaira Y, Kaneko Y, Yagita H, Obata Y.
    J Immunol; 1998 Jun 01; 160(11):5253-61. PubMed ID: 9605121
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.